 For the United States Supreme Court, because we have these massive outstanding cases. And given the lineup, there are two cases outstanding from December where Roberts and Gorsuch haven't issued opinions. So we can expect that several of them, there's the Purdue Pharma case, the Jarkese SEC case. They're probably authoring those. In January, there's still a case outstanding. And you've got the Luper Bright case.